Skip to main content

Table 3 Comparison of life quality scale EORTC QLQ-C30 scores before and after treatment

From: Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer

 

Research group

  

Control group

  
 

Follow-up

Before treatment

P

Follow-up

Before treatment

P

Symptom

27.1 ± 3.3

42.7 ± 5.2

< 0.001

29.8 ± 5.0

42.4 ± 5.0

< 0.001

Functional

40.2 ± 3.3

23.8 ± 3.0

< 0.001

32.8 ± 2.5

23.3 ± 3.3

< 0.001

Total

7.1 ± 1.1

3.2 ± 0.3

< 0.001

5.70 ± 1.0

3.1 ± 0.3

< 0.001